Research
Energy balance
Endoscopic sleeve gastroplasty (ESG) added 0.06 quality-adjusted life-years (QALYs) and reduced total cost by $33,583 relative to semaglutide.
This indicates that ESG not only provides health benefits but also reduces overall treatment costs.
StrongSupportsmedium confidence
Endoscopic sleeve gastroplasty added 0.06 QALYs and reduced total cost by $33 583 relative to semaglutide.
Why this rating
Based on the economic evaluation study design.
Source
Semaglutide vs Endoscopic Sleeve Gastroplasty for Weight Loss
Muhammad Haseeb et al. · JAMA Network Open · 2024
otherCited 66×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →